For: | Matsuoka T, Yashiro M. Molecular-targeted therapy toward precision medicine for gastrointestinal cancer: Current progress and challenges. World J Gastrointest Oncol 2021; 13(5): 366-390 [PMID: 34040699 DOI: 10.4251/wjgo.v13.i5.366] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i5/366.htm |
Number | Citing Articles |
1 |
Qianqian Wang, Chao Huang, Ying Ding, Shaodi Wen, Xin Wang, Shuwei Guo, Qiuzhi Gao, Zhihong Chen, Yuanyuan Zhao, Mei Wang, Bo Shen, Wei Zhu. Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.884373
|
2 |
Ming Li, Ou Cai, Yuanjie Yu, Shiyun Tan. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis. Phytomedicine 2022; 96: 153903 doi: 10.1016/j.phymed.2021.153903
|
3 |
燕秋 文. Modern Treatment Strategies for Advanced Gastric Cancer: Comprehensive Evaluation and Future Directions. Journal of Clinical Personalized Medicine 2024; 3(02): 199 doi: 10.12677/jcpm.2024.32029
|
4 |
Gideon T. Dosunmu, Ardaman Shergill. Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine. Genes 2024; 15(5): 538 doi: 10.3390/genes15050538
|
5 |
Siddharth Menon, Sagun Parakh, Andrew M. Scott, Hui K. Gan. Antibody-drug conjugates: beyond current approvals and potential future strategies. Exploration of Targeted Anti-tumor Therapy 2022; : 252 doi: 10.37349/etat.2022.00082
|
6 |
Fei Jiang, Guangxi Liu, Xiaowei Chen, Qiong Li, Fujin Fang, Xiaobing Shen. Hsa_circ_0044301 Regulates Gastric Cancer Cell’s Proliferation, Migration, and Invasion by Modulating the Hsa-miR-188-5p/DAXX Axis and MAPK Pathway. Cancers 2022; 14(17): 4183 doi: 10.3390/cancers14174183
|